Article Text

other Versions

PDF
The contribution of Fc gamma receptor IIIA gene 158V/F polymorphism and copy number variation to the risk of ACPA positive rheumatoid arthritis
  1. M M Thabet (m.thabet{at}lumc.nl)
  1. Leiden University Medical Center, Netherlands
    1. T WJ Huizinga (t.w.j.huizinga{at}lumc.nl)
    1. Leiden University Medical Center, Netherlands
      1. R B Marques (r.b.marques{at}lumc.nl)
      1. Leiden University Medical Center, Netherlands
        1. G Stoeken-Rijsbergen (g.stoeken-rijsbergen{at}lumc.nl)
        1. Leiden University Medical Center, Netherlands
          1. A M Bakker (a.m.bakker{at}lumc.nl)
          1. Leiden University Medical Center, Netherlands
            1. F A Kurreeman (b.a.s.kurreeman{at}lumc.nl)
            1. Leiden University Medical Center, Netherlands
              1. SJ White (stefan.white{at}mcri.edu.au)
              1. Murdoch Childrens Research Institute, Royal Children's Hospital, Australia
                1. R EM Toes (r.e.m.toes{at}lumc.nl)
                1. Leiden University Medical Center, Netherlands
                  1. A HM van der Helm-van Mil (avdhelm{at}lumc.nl)
                  1. Leiden University Medical Center, Netherlands

                    Abstract

                    Objectives: Fcγ-receptors (FcγRs) are potent immune-modulators. FcγRs-genes encompass a complex region, polymorphic by both single nucleotide polymorphisms (SNPs) and copy number variation (CNV). The heterogeneity of rheumatoid arthritis (RA) combined with the genetic-complexity of FcγRs-genes may be the cause of inconsistent findings in previous RA-studies on FcγR-SNPs. Since there is increasing evidence that anti-citrullinated peptide antibodies (ACPA)-positive RA and ACPA-negative RA have different genetic background, we investigated whether FcγRIIIA158V/F-SNP differently associates with ACPA-positive and ACPA-negative RA. Moreover, this study is the first to assess whether FcγRIIIA-gene CNV affects the association of the FcγRIIIA158V/F-SNP with RA and if FcγRIIIA-gene CNV confers risk to RA.

                    Methods: This study comprises 945 RA patients and 388 healthy controls, all Dutch-Caucasians. FcγRIIIA158V/F-SNP was genotyped using Sequenom. CNV of FcγRIIIA-gene was determined in 456 RA patients and 285 controls using Multiplex Ligation-dependent Probe Amplification (MLPA). Associations between genotypes and RA were analysed stratifying for the presence/absence of ACPA and CNV.

                    Results: In all RA patients the FcγRIIIA158V/F-SNP was not associated with RA. In ACPA+RA (N=358), the VV-genotype was more prevalent in cases than controls (18.4% versus 13.2%, OR=1.5, P=0.05). After stratification for CNV the VV-genotype was associated with RA in general (N=426) (OR=1.6, 95%CI 0.97-2.6, P=0.05) and with ACPA+RA (N=135) (OR=2.1, 95%CI 1.2-3.8, P=0.009) but not with ACPA-RA. The distribution of CNV was not significantly different between RA-patients and controls.

                    Conclusion: The FcγRIIIA-158 VV-genotype confers risk to ACPA+RA; this association increased slightly after correction for CNV of the FcγRIIIA-gene. CNV itself was not associated with RA-susceptibility.

                    Statistics from Altmetric.com

                    Request permissions

                    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.